dotMD.com
Join Community
📖Formal Study Breakdown Talk in GLP-1s, Weight & Muscle Space 711+ Logs • Free →🧮Lab Calculator ↓
Reading this clinical breakthrough? See how real patients are applying these numbers in real life. Compare GLP-1 titration schedules, nausea fixes, and protein routines—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to GLP-1s, Weight & Muscle Space (15 Seconds • No Account or Email Required)
Or read existing discussions in GLP-1s, Weight & Muscle Space →
Back to Plain-English 8th-Grade Story
Google Scholar NIH PubMed #41940793
Official NIH NLM MEDLINE / PubMed Citation • PMID: 41940793

Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

Diabetes Care

Verbatim Formal Study Abstract

Analyses included 2,055 of 9,901 participants from REWIND and all 13,165 participants from SURPASS-CVOT.